Antibody De Novo Sequencing
The amino acid sequence of therapeutic antibody plays a critical role in the rising biopharmaceutical industry for antibody drug discovery and development, regulatory filing and intellectual property protection.
De Novo sequencing of therapeutic antibodies and other proteins is a technology to sequence the proteins without the database searching, and get the sequence by LC-MS/MS, software processing, and bioinformatics.